Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neurovirology

• Publication date

  2009-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/13550280903131915PMID 20175693PMCID PMC3078805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiretroviral therapy and central nervous system HIV type 1 infection.

  2008cited by this paper
• Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

  2008cited by this paper
• Neurocognitive disturbances in HIV

  2008influential reference
• The Neuropathology of HIV/AIDS

  2008cited by this paper
• Dementia and Neurocognitive Disorders Due to HIV-1 Infection

  2007cited by this paper
• Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment

  2006cited by this paper
• Nevirapine Uptake into the Central Nervous System of the Guinea Pig: An in Situ Brain Perfusion Study

  2006cited by this paper
• Diminished somatostatin gene expression in individuals with HIV and major depressive disorder

  2006influential reference
• Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV‐infected cohort: experience of the National NeuroAIDS Tissue Consortium

  2006cited by this paper
• Nature of depression in patients with HIV/AIDS.

  2005cited by this paper
• Initial Validation of a Screening Battery for the Detection of HIV-Associated Cognitive Impairment

  2004cited by this paper
• Anti-HIV drug distribution to the central nervous system.

  2004cited by this paper
• Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV

  2004cited by this paper
• An update on the neuropathology of HIV in the HAART era

  2004cited by this paper
• Changing Patterns in the Neuropathogenesis of HIV During the HAART Era

  2003cited by this paper
• Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time.

  2002cited by this paper
• Antiretroviral therapy regimens for neuro-AIDS.

  2002cited by this paper
• Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis

  2002influential reference
• The National NeuroAIDS Tissue Consortium:a new paradigm in brain banking with an emphasis on infectious disease

  2001influential reference
• Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

  2001influential reference
• Changes in pathological findings at autopsy in AIDS cases for the last 15 years

  2000influential reference
• Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder

  1999cited by this paper
• Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders

  1997cited by this paper
• HIV‐associated brain pathology in the United Kingdom: an epidemiological study

  1997influential reference
• Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients

  1996cited by this paper
• Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia

  1995cited by this paper
• The HNRC 500-Neuropsychology of Hiv infection at different disease stages

  1995cited by this paper
• Neuronal loss in the frontal cortex in HIV infection.

  1991cited by this paper
• Cross-cultural Feasibility, Reliability and Sources of Variance of the Composite International Diagnostic Interview (CIDI)

  1991cited by this paper
• Neuropathology of Human Immunodeficiency Virus Infection

  1991cited by this paper
• HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology

  1991influential reference

• Neuropathologic findings in a community-based autopsy cohort of older, virally suppressed, people with HIV

  2025cites this paper
• Single-Cell Multi-Modal Differential Analysis of the Human Neo-Cortex in HIV Infection Reveals Similarities with Hallmarks of Alzheimer’s Disease

  2025cites this paper
• Cortical White and Grey Matter Volume Differences Associated with Plasma Cytokine and Chemokine Levels in PLWH in Cape Town

  2025cites this paper
• HIV-associated neurocognitive disorders (HAND): Optimal diagnosis, antiviral therapy, pharmacological treatment, management, and future scopes.

  2025cites this paper
• HIV and COVID-19: two pandemics with significant (but different) central nervous system complications.

  2024cites this paper
• Crosstalk between gut microbiome and neuroinflammation in pathogenesis of HIV-associated neurocognitive disorder.

  2024cites this paper
• Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review

  2024cites this paper
• Apathy in persons living with HIV disease: A systematic narrative review.

  2024cites this paper
• The single-cell opioid responses in the context of HIV (SCORCH) consortium

  2024cites this paper
• Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function

  2023cites this paper
• Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology

  2023cites this paper
• Elevated frequency and everyday functioning implications of vascular depression in persons with HIV disease.

  2023cites this paper
• Neuro-immune deconvolution analysis of OAS3 as a transcriptomic central node in HIV-associated neurocognitive disorders.

  2023cites this paper
• Predictors of hippocampal tauopathy in people with and at risk for human immunodeficiency virus infection

  2023cites this paper
• Association of apolipoprotein E epsilon 4 and cognitive impairment in adults living with human immunodeficiency virus: a meta-analysis

  2022cites this paper
• Longitudinal white matter alterations in SIVmac239-infected rhesus monkeys with and without regular cART treatment

  2022cites this paper
• Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV

  2022cites this paper
• Neuroinflammation in HIV-associated depression: evidence and future perspectives

  2022cites this paper
• Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats

  2022cites this paper
• Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective

  2022cites this paper
• Antiretroviral therapy restores the homeostatic state of microglia in SIV‐infected rhesus macaques

  2022cites this paper
• HIV‐induced neuroinflammation inhibits oligodendrocyte maturation via glutamate‐dependent activation of the PERK arm of the integrated stress response

  2021cites this paper
• Central nervous system (CNS) transcriptomic correlates of human immunodeficiency virus (HIV) brain RNA load in HIV-infected individuals

  2021cites this paper
• Cardio‐ankle vascular index of increased arterial wall stiffness is associated with neurocognitive impairment in well‐controlled HIV

  2021cites this paper
• Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV

  2021cites this paper
• Advances in the Experimental Models of HIV-Associated Neurological Disorders

  2021cites this paper
• Cognitive Differences between Men and Women with HIV: A Systematic Review and Meta-Analysis.

  2021cites this paper
• Transcriptomic and Genetic Profiling of HIV-Associated Neurocognitive Disorders

  2021cites this paper
• Proinflammatory Cytokines and Chemokines are Related to MRI Measures of White and Gray Matter in HIV Infection

  2021cites this paper
• HIV-1 PERSISTENCE IN THE CNS: MECHANISMS OF LATENCY, PATHOGENESIS AND AN UPDATE ON ERADICATION STRATEGIES.

  2021cites this paper
• HIV-Associated CD8 Encephalitis: A UK Case Series and Review of Histopathologically Confirmed Cases

  2021cites this paper
• Detection of H3K4me3 Identifies NeuroHIV Signatures, Genomic Effects of Methamphetamine and Addiction Pathways in Postmortem HIV+ Brain Specimens that Are Not Amenable to Transcriptome Analysis

  2021cites this paper
• A review of potential microbiome-gut-brain axis mediated neurocognitive conditions in persons living with HIV

  2020cites this paper
• Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders.

  2020cites this paper
• Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior

  2020cites this paper
• Cross-sectional Study of Clinical and Psycholinguistic Characteristics of Mental Disorders in HIV Infection

  2020cites this paper
• Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease

  2020cites this paper
• HIV-Associated Neurocognitive Disorder (HAND)

  2020cites this paper
• Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research

  2020influential citation
• HIV and opiates dysregulate K+-Cl- cotransporter 2 (KCC2) to cause GABAergic dysfunction in primary human neurons and Tat-transgenic mice.

  2020cites this paper
• Increases in compulsivity, inflammation, and neural injury in HIV transgenic rats with escalated methamphetamine self-administration under extended-access conditions.

  2020cites this paper
• Osteopontin/Secreted Phosphoprotein-1 Behaves as a Molecular Brake Regulating the Brain Translocator Protein-Dependent Neuroin ammatory Response to Chronic Viral Infection

  2020cites this paper
• A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders

  2020cites this paper
• Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies

  2020cites this paper
• Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders.

  2020cites this paper
• Efficient Expression of HIV in Immunocompetent Mouse Brain Reveals a Novel Nonneurotoxic Viral Function in Hippocampal Synaptodendritic Injury and Memory Impairment

  2019cites this paper
• Protease Inhibitors, Saquinavir and Darunavir, Inhibit Oligodendrocyte Maturation: Implications for Lysosomal Stress

  2019cites this paper
• Smaller limbic structures are associated with greater immunosuppression in over 1000 HIV-infected adults across five continents: Findings from the ENIGMA-HIV Working Group

  2019cites this paper
• JAIDS: Journal of Acquired Immune Deficiency Syndromes COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk for HIV-associated Neurocognitive Impairment

  2019cites this paper
• Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats

  2019cites this paper
• COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk for Neurocognitive Impairment in Men Living with HIV.

  2019cites this paper
• Reversal of Cognitive Impairment in gp120 Transgenic Mice by the Removal of the p75 Neurotrophin Receptor

  2019cites this paper
• Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder

  2019cites this paper
• White Matter Abnormalities Linked to Interferon, Stress Response, and Energy Metabolism Gene Expression Changes in Older HIV-Positive Patients on Antiretroviral Therapy

  2019cites this paper
• Progressive brain atrophy in chronically infected and treated HIV+ individuals

  2019cites this paper
• White matter loss and oligodendrocyte dysfunction in HIV: a consequence of the infection, the antiretroviral therapy or both?

  2019cites this paper
• Druggable Targets of the Endocannabinoid System: Implications for the Treatment of HIV-Associated Neurocognitive Disorder.

  2019cites this paper
• Pathogenesis of age-related HIV neurodegeneration

  2019cites this paper
• The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease

  2019cites this paper
• Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy

  2019cites this paper
• Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer’s disease?

  2019cites this paper
• HIV neuropathology.

  2018cites this paper
• Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi.

  2018cites this paper
• A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates

  2018cites this paper
• Purinergic Signaling: A New Pharmacological Target Against Viruses?

  2018cites this paper
• Alzheimer’s disease neuropathology may not predict functional impairment in HIV: a report of two individuals

  2018cites this paper
• Brain-specific HIV Nef identified in multiple patients with neurological disease

  2018cites this paper
• HIV induces synaptic hyperexcitation via cGMP-dependent protein kinase II activation in the FIV infection model

  2018cites this paper
• THE MINISTRY OF SCIENCE AND HIGHER EDUCATION OF THE RUSSIAN FEDERATION

  2018cites this paper
• Deficient Emotion Processing is Associated with Everyday Functioning Capacity in HIV-associated Neurocognitive Disorder

  2018cites this paper
• Role of microglia in methamphetamine-induced neurotoxicity.

  2017cites this paper
• Genetic, Epigenetic, and Transcriptomic Studies of NeuroAIDS

  2017cites this paper
• The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature

  2017cites this paper
• The Persistence of HIV-Associated Neurocognitive Disorder (HAND) in the Era of Combined Antiretroviral Therapy (cART)

  2017cites this paper
• An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

  2017cites this paper
• Head and heart in treated HIV infection

  2017cites this paper
• Therapeutic Considerations in HIV-Associated Neurocognitive Disorders

  2017cites this paper
• Vascular Contributions to Neurocognitive Impairment among Older Persons with HIV

  2017cites this paper
• Topological Organization of Whole-Brain White Matter in HIV Infection

  2017cites this paper
• Neuropathology of HIV-1 Disease

  2017cites this paper
• The Role of Early Life Programming in Vulnerability and Resilience in Relation to HIV

  2017cites this paper
• Global Virology II - HIV and NeuroAIDS

  2017cites this paper
• A mouse model of HIV-associated neurocognitive disorders: a brain-behavior approach to discover disease mechanisms and novel treatments

  2017cites this paper
• Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era

  2017cites this paper
• Real-World Impact of HIV-Associated Neurocognitive Impairment

  2017cites this paper
• HIV-Associated Neurocognitive Disorders

  2017cites this paper
• HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment

  2017cites this paper
• Gene expression patterns associated with neurological disease in human HIV infection

  2017cites this paper
• The effects of the HIV-1 Tat protein and morphine on the structure and function of the hippocampal CA1 subfield

  2017influential citation
• The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons

  2016cites this paper
• Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV

  2016cites this paper
• HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

  2016cites this paper
• Smoothened Agonist Reduces Human Immunodeficiency Virus Type-1-Induced Blood-Brain Barrier Breakdown in Humanized Mice

  2016cites this paper
• [Advances of immunological pathogenesis research in HIV related neurocognitive disorder].

  2016cites this paper
• Characterization of neuropathology in the HIV-1 transgenic rat at different ages.

  2016cites this paper
• Gene expression patterns associated with neurological disease in HIV infection

  2016cites this paper
• Impact of Depression and Inflammation on the Progression of HIV Disease

  2016cites this paper
• The neurotrophin receptor p75 mediates gp120-induced loss of synaptic spines in aging mice.

  2016cites this paper
• Identification of a binding site of the human immunodeficiency virus envelope protein gp120 to neuronal‐specific tubulin

  2016cites this paper
• The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model.

  2016cites this paper